Alteplase deemed life saving and cost effective - GUSTO data Tracey LangsdaleCarlene Todd Newsletter Article 17 February 2013 Pages: 3 - 4
Do generics reduce costs to the detriment of quality? Newsletter Article 17 February 2013 Pages: 5 - 5
Education and self-management cost effective in asthma? Newsletter Article 17 February 2013 Pages: 6 - 6
Modelling the cost effectiveness of SSRI prophylaxis Newsletter Article 17 February 2013 Pages: 7 - 7
Against the use of costly, unproven antihypertensives Newsletter Article 17 February 2013 Pages: 7 - 7
Economics of ‘Neoral’ vs ‘Sandimmun’ in renal transplantation Newsletter Article 17 February 2013 Pages: 8 - 8
Cardiac rehabilitation reduces healthcare consumption Newsletter Article 17 February 2013 Pages: 8 - 8
Dramatic cost savings with asthma outreach programme Newsletter Article 17 February 2013 Pages: 9 - 9
Intensive case management cost saving in psychiatric disorders Newsletter Article 17 February 2013 Pages: 9 - 9
Interferon-α-2b saves lives and societal resources Newsletter Article 17 February 2013 Pages: 11 - 11
Cost analysis of rotavirus vaccination for infants Newsletter Article 17 February 2013 Pages: 11 - 11
Community clinical pharmacy service reduces prescribing costs Newsletter Article 17 February 2013 Pages: 12 - 12
Assessing the impact of illness from a child’s perspective Newsletter Article 17 February 2013 Pages: 13 - 13
Which illnesses are appropriate for disease management? Newsletter Article 17 February 2013 Pages: 15 - 15